Karyopharm Therapeutics
KPTI
#11303
Rank
ยฃ0.3 M
Marketcap
ยฃ0.01330
Share price
0.00%
Change (1 day)
-99.70%
Change (1 year)

Karyopharm Therapeutics (KPTI) Fails to deliver data

Key failure to deliver metrics for Karyopharm Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Karyopharm Therapeutics (KPTI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Karyopharm Therapeutics (KPTI) - since 2013

Volume in USD (price x number of shares), data since 2013

Karyopharm Therapeutics (KPTI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024ยฃ1.16 M-97.87%
2023ยฃ54.81 M18.97%
2022ยฃ46.07 M5.78%
2021ยฃ43.55 M77.73%
2020ยฃ24.5 M33.34%
2019ยฃ18.38 M106.04%
2018ยฃ8.92 M-65.24%
2017ยฃ25.66 M334.29%
2016ยฃ5.9 M-84.55%
2015ยฃ38.24 M-42.24%
2014ยฃ66.21 M11206.31%
2013ยฃ0.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Abbott Laboratories
ABT
ยฃ8.15 Mยฃ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ29.88 Mยฃ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ19.01 Mยฃ94.54 M๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ6.19 Mยฃ30.17 M๐Ÿ‡บ๐Ÿ‡ธ USA